XML 19 R6.htm IDEA: XBRL DOCUMENT v3.19.1
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY - USD ($)
$ in Thousands
Shares of Common Stock
Common Stock and Additional Paid in Capital
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Total
Balance, beginning of period at Dec. 31, 2016   $ 61,583 $ 17,206 $ (180) $ 78,609
Balance (in shares) at Dec. 31, 2016 6,263,371        
Increase (Decrease) in Shareholders' Equity          
Net income     5,479   5,479
Other comprehensive income (loss):          
Net change in unrealized gain on securities available for sale       42 42
Actuarial loss on defined benefit pension obligation       (106) (106)
Total comprehensive income       (64) 5,415
Stock compensation   398     398
Restricted stock award vesting (in shares) 31,559        
Reclassification of certain deferred tax effects     48 (48)  
Dividend on common stock     (3,022)   (3,022)
Balance, end of period at Dec. 31, 2017   61,981 19,711 (292) 81,400
Balance (in shares) at Dec. 31, 2017 6,294,930        
Increase (Decrease) in Shareholders' Equity          
Net income     8,367   8,367
Other comprehensive income (loss):          
Net change in unrealized gain on securities available for sale       (174) (174)
Actuarial loss on defined benefit pension obligation       3 3
Total comprehensive income       (171) 8,196
Stock compensation   533     533
Restricted stock award vesting (in shares) 45,630        
FFNM acquisition   34,101     $ 34,101
FFNM acquisition (in shares) 2,146,378       2,146,378
Capital raise, net of offering costs   32,451     $ 32,451
Capital raise, net of offering costs (in shares) 2,225,807        
Dividend on common stock     (4,612)   (4,612)
Balance, end of period at Dec. 31, 2018   $ 129,066 $ 23,466 $ (463) $ 152,069
Balance (in shares) at Dec. 31, 2018 10,712,745